University of Thessaly (UTH)
Μελέτη φυσικών και συνθετικών ενώσεων με αντιγηραντική δράση και δράση εναντίον της πρωτεϊνικής συσσωμάτωσης σε οργανισμικά και κυτταρικά μοντέλα γήρανσης
Abstract
dc:descriptionIn this doctoral thesis, we studied two compounds that structurally activate the 20S proteasome, likely through direct stereochemical interactions. These compounds demonstrated anti-aging properties and reduced protein aggregation in cellular and organismal aging models. In the first part of the thesis, we identified for the first time a natural compound isolated from the brown alga Dictyota mediterranea as a structural proteasome activator, named (1R,3E,6R,7Z,11S,12S)-dolabella-3,7,18-trien-6,17-olide (DBTO). DBTO activates the 20S proteasome both in vitro (in the absence of cell lysates) and in cellulo. Continuous administration of DBTO to young, human primary fibroblasts (HFL-1) throughout their replicative lifespan improves cellular healthspan. Similarly, DBTO administration improves the health status of wild-type Caenorhabditis elegans nematodes. Furthermore, DBTO administration in transgenic Alzheimer’s disease models of C. elegans and human neuroblastoma cells (SH-SY5Y) exposed to Aβ peptide enhances protection against Aβ-induced proteotoxicity.In the second part of the thesis, the hybrid compound MK151, combining the structural features of hydroxytyrosol and chroman (the pharmacophore of vitamin E) in one scaffold, was identified as a structural 20S proteasome activator in vitro (in the absence of cell lysates), in cellulo, and in vivo following administration in wild-type C. elegans. Continuous MK151 administration to young, human primary fibroblasts (HFL-1) throughout their replicative lifespan extends lifespan and improves cellular healthspan. Likewise, improvement of organismal healthspan is also observed in wild-type C. elegans nematodes treated with MK151. Additionally, MK151 administration in transgenic Alzheimer’s disease models of C. elegans provides enhanced protection against Aβ-induced proteotoxicity. Moreover, the synthesis of optimized MK151 analogs yielded compounds that structurally activate the 20S proteasome in vitro (in the absence of cell lysates) and exhibit similar or even superior anti-aging and/or neuroprotective effects in C. elegans and human primary fibroblasts (HFL-1). In total, our results reveal two structural proteasome activators: DBTO, a metabolite derived from a Mediterranean marine organism and the bio-inspired synthetic compound MK151, highlighting their potential as agents to improve or preserve healthspan and provide preventive protection against age-related diseases characterized by protein aggregation, such as Alzheimer’s disease.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vasilopoulou, Maria
- Βασιλοπούλου, Μαρία
Subjects
dc:subject × 33- Γήρανση
- Πρωτεάσωμα
- Ενεργοποίηση πρωτεασώματος
- Νόσος Αλτσχάιμερ
- Ευζωΐα
- Αντιγήρανση
- Γήρανση, Μοριακή και κυτταρική
- Φυσικές ενώσεις
- Συνθετικές ενώσεις
- Πρωτεϊνική συσσωμάτωση
- Ageing
- Proteasome
- Proteasome activation
- Alzheimer's disease
- Healthspan
- Antiageing
- Molecular and cellular ageing
- Natural compounds
- Synthetic compounds
- Protein aggregation
- Βιολογία
- Φυσικές Επιστήμες
- Βιοχημεία και Μοριακή βιολογία
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Biological Sciences
- Natural Sciences
- Biology
- Biochemistry and Molecular Biology
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59870